Award
Delivery Order #SPE2DR26FDF3C
Pharmaceutical Delivery Order Awarded to AmerisourceBergen for RINVOQ Tablets
Buyer
Defense Logistics Agency
Award Amount
$20,637.10
Ceiling
$20,637.10
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26FDF3C
NAICS
424210
This contract is a delivery order awarded to AmerisourceBergen Drug Corp under an existing indefinite delivery vehicle (IDV) focused on pharmaceutical procurement. AmerisourceBergen, a leading pharmaceutical sourcing and distribution company, is tasked with supplying RINVOQ ER 15 MG tablets in prescribed quantities. The significance of this contract lies in its support of federal healthcare infrastructure by ensuring the timely and reliable supply of critical medication. The scope includes the delivery of these pharmaceutical products within a short period, demonstrating the contract's role in meeting urgent healthcare demands. This award was made as a component of the broader strategic pharmaceutical supply contract, which was competitively established to maintain consistent access to essential drugs. The period of performance for this delivery order is a focused timeframe in early 2026, aligning with the overarching long-term agreement spanning from 2025 through 2036. This contract exemplifies ongoing efforts to provide the federal supply chain with critical pharmaceuticals through reliable sourcing and timely distribution.
Description
4570834450!RINVOQ ER 15 MG TABLET UU 30S